There are other blood disorders that present unique issues for women and girls. These include, but are not limited to, Immune Thrombocytopenic Purpura (ITP) and anemias. Women and adolescent girls with thrombocytopenia due to ITP or bone marrow failure face many of the bleeding complications seen in females with inherited bleeding disorders, as well as complications related to treatment, particularly in pregnancy (Gernsheimer, T and McCrae, KR, 2007). Chemotherapy-induced thrombocytopenia (CIT) is another concern for women that is growing in prevalence. When patients experience CIT, they are at risk for serious side effects such as a greater risk of bleeding. This condition may become severe enough that physicians may have to reduce the doses of chemotherapy. FWGBD will build the education resource base in these important areas as well.